Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TEAD1 inhibitors(TEA domain transcription factor 1 inhibitors), TEAD4 inhibitors(TEA domain transcription factor 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | 17 Apr 2023 |